E. Martínez-Vila, P. Irimia
8. ALBERS GW, HART RG, LUTSEP HL, NEWELL DW, prospective cohorts. Lancet 1995; 346: 1647-
SACCO RL. Supplement to the Guidelines for 1653.
the management of transient ischemic 11. CLARKE R, DALY L, ROBINSON K, NAUGHTEN E,
attacks. A statement from the ad hoc CAHALANE S, FOWLER B, et al. Hyperhomo-
committee on guidelines for the cysteinemia: an independent risk factor for
management of transient ischemic attacks, vascular disease. N Eng J Med 1991; 324:
Stroke Council, American Heart Association. 1149-1155.
Stroke 1999; 30: 2502-2511.
12. AMARENCO P, DUYCKAERTS C, TZOURIO C, HENIN D,
9. UK Prospective Diabetes Study Group. BOUSSER MG, HAUW JJ. The prevalence of
Intensive blood pressure control and risk of ulcerated plaques in the aortic arch in
macrovascular and microvascular patients with stroke. N Engl J Med 1992; 326:
complications in type 2 diabetes: UKPDS 38. 221-225.
B Med J 1998; 317: 703-713.
13. Executive Committee of Asymptomatic
10. Prospective Studies Collaboration: Carotid Atheroesclerosis Study:
cholesterol, diastolic blood pressure, and endarterectomy for asymptomatic carotid
stroke: 13.000 strokes in 450.000 people in 45 stenosis. JAMA 1995; 273: 1421-1428.